You'll continue to hear buzz about Avandia (rosiglitazone)

January 2014

You'll continue to hear buzz about Avandia (rosiglitazone)...due to loosening of prescribing restrictions in the U.S.

This decision is based on some experts saying there's not enough evidence that Avandia increases the risk of heart attacks.

But don't expect to see an increase in Avandia Rxs. Other experts feel Avandia is still risky...and most patients have moved on to pioglitazone or other diabetes meds.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Opioids the rampant misuse and abuse of opioids (oxycodone, etc) and other controlled drugs
Allergic Reactions how to handle dye allergies
Insulin Sliding scale insulin is giving patients a ride on the blood glucose roller coaster
Contraceptives whether levonorgestrel emergency contraceptives (Plan B, Next Choice, etc) are effective in heavier women
Statins how to avoid problems with statins
Interactions how to handle drug interaction alerts for clarithromycin with calcium channel blockers (amlodipine, etc)
Diabetes Meds You'll continue to hear buzz about Avandia (rosiglitazone)
COPD help prevent hospital admissions for chronic obstructive pulmonary disease (COPD)
Vaccines using Prevnar 13 in ADULTS
Pediatrics increasing use of SSRIs (fluoxetine, citalopram, sertraline, etc) in children and adolescents
Pregnancy using ondansetron (Zofran, etc) for morning sickness
Healthy Lifestyles New lifestyle guidelines will help patients with New Year's resolutions to improve their health and lower heart risk

You'll continue to hear buzz about Avandia (rosiglitazone)

Practical advice for a better career, with unlimited access to CE

Table of Contents